Literature DB >> 1618257

Absence of interaction between tenoxicam and warfarin.

H G Eichler1, M Jung, P A Kyrle, M Rotter, A Korn.   

Abstract

The influence of tenoxicam on plasma warfarin concentrations and on its anticoagulant effect has been studied in healthy volunteers. Tenoxicam did not alter the plasma warfarin concentration versus time profile. Treatment with it for 14 days had no effect on the average dose of warfarin required to maintain the prothrombin time within a specified range. The coumarin dose index, an indicator of warfarin sensitivity, remained unchanged during tenoxicam administration. The results demonstrate the lack of a clinically relevant effect of tenoxicam on warfarin-induced anticoagulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618257     DOI: 10.1007/bf00278491

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  [Testing of the antirheumatic agent tolmetin for its interactions with oral anticoagulants].

Authors:  O Rüst; L Biland; D Thilo; D Nyman; F Duckert
Journal:  Schweiz Med Wochenschr       Date:  1975-06-07

2.  [Drug interactions in therapy using coumarin derivatives].

Authors:  R Gugler
Journal:  Internist (Berl)       Date:  1979-05       Impact factor: 0.743

Review 3.  Drug interactions with coumarin anticoagulants. 2.

Authors:  J K Weser; E Sellers
Journal:  N Engl J Med       Date:  1971-09-02       Impact factor: 91.245

4.  Lack of interaction between ibuprofen and warfarin.

Authors:  J A Penner; P H Abbrecht
Journal:  Curr Ther Res Clin Exp       Date:  1975-12

Review 5.  Oxicams--a novel family of non-steroidal anti-inflammatory drugs.

Authors:  E H Wiseman; J G Lombardino
Journal:  Eur J Rheumatol Inflamm       Date:  1981

6.  Determination of Ro12-0068, a new anti-inflammatory and analgesic compound, in plasma by means of high-performance liquid chromatography.

Authors:  M E Pickup; J R Lowe; D B Galloway
Journal:  J Chromatogr       Date:  1981-10-09

Review 7.  Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  J P Gonzalez; P A Todd
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

8.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

9.  Determination of the anticoagulant phenprocoumon in human plasma and urine by high-performance liquid chromatography.

Authors:  J X De Vries; J Harenberg; E Walter; R Zimmermann; M Simon
Journal:  J Chromatogr       Date:  1982-08-13
  9 in total
  4 in total

1.  Lack of interaction between meloxicam and warfarin in healthy volunteers.

Authors:  D Türck; C A Su; G Heinzel; U Busch; E Bluhmki; J Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

Review 2.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of tenoxicam.

Authors:  O G Nilsen
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

Review 4.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.